Brief: Ikena Oncology Reports Q1 Loss Per Share Of $2.52
May 13 (Reuters) - Ikena Oncology Inc IKNA.O :
* IKENA ONCOLOGY REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS AND
OUTLINES KEY CORPORATE OBJECTIVES FOR 2021
* IKENA ONCOLOGY - QTRLY LOSS PER SHARE $2.52
* Q1 EARNINGS PER SHARE VIEW $-0.68 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw8Vb050a
Further company coverage: IKNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImageneBio
See all newsU.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
Brief: ImageneBio Inc - On Oct 23, Elects Not To Renew Agreement With Miragene - SEC Filing
ImageneBio Inc expected to post a loss of $1.56 a share - Earnings Preview
Brief: Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals